Survey In Research : Global Psoriasis Therapeutics Market Trends 2012-2016

Global Psoriasis Therapeutics market to grow at a CAGR of 4.06 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing uptake of biologics. The Global Psoriasis Therapeutics market has also been witnessing an increased focus on using combination therapies for treating psoriasis. However, the adverse side effects associated with psoriatic drugs could pose a challenge to the growth of this market.

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/global-psoriasis-therapeutics-market-2012-2016

Global Psoriasis Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Psoriasis Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Amgen Inc., Pfizer Inc., Janssen Biotech Inc., and Abbvie Inc.

The other vendors mentioned in the report are AstraZeneca plc, Bristol Myers Squibb Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck & Co. Inc., and Novartis International AG

To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172952 

UCB S.A. Key questions answered in this report:

What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

To  Read The Reports: http://cmd.me/worldwide-business-survey-global-psoriasis-therapeutics-market-trends-2012-2016/

MArket Researchreports: Global Beverage Can Market Research Report: 2013 New Release

Packaging is one of the factors critical to product marketing strategy with the key objective of glamorizing product for directing consumers’ attention. Packaging’s key purpose is to protect the content it stores and to enhance the visual and physical properties that make it stand out from the crowd, and connect with consumers as part of the brand experience. There are various types of materials used in packaging and also different types of packaging containers are manufactured and deployed across consumer products industries. ‘Cans’ is one such segment within the consumer packaging industry.

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/global-beverage-can-market-report-2013-edition 

Metal cans are used for packing wide range of products, including beverages, processed foods, aerosol products, paints, medicines and many other products. Most cans are cylindrical in shape. A beverage can is a metal container devised to store a fixed amount of liquid products like carbonated soft drinks, alcoholic beverages, fruit juices, teas, tisanes, and energy drinks among others. Beverage cans are either made of aluminum or tin-plated steel. Metal beverage cans and their parts are primarily made from aluminum and steel, and are usually offered in two and three piece varieties.

Geographically, Europe and Asia & EMEA are the largest packaging industries while in terms of end market demand, food and beverages industries account for the maximum usage. Taking into account the type of materials used in manufacturing packaging containers, flexible packaging tops the list, however rigid plastics and metals are the major materials of choice. Within the metal packaging, the maximum usage is claimed by beverage can manufacturing segment.

Table of Content

1. Overview
1.1 Packaging
1.2 Metal Cans
1.2.1 Beverage Can

2. Packaging Industry Structure
2.1 Global Packaging Market
• Breakdown by Region
• End Markets
• Key Segments
2.1.1 Aluminum Aerosol Can Market
• Demand Growth
• End Markets
2.2 Global Beverage Can Industry
• Market Overview
• Market Volume
2.2.1 Beverage Can Market of the US
• Shipment Growth
• Key Segments
2.2.2 Beverage Can Market of Europe
• Shipment Growth
• Key Segments
• Regional Breakdown
• Central & Eastern Europe
• Russia & Former CIS
2.2.3 Beverage Can Market of China
• Market Overview
• End Markets

To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172608

3. Market Dynamics
3.1 Industry Trends and Developments
3.1.1 Eco-Friendly and Self-Chilling Beverage Cans
3.1.2 Next Generation Beverage Can Tab and Can End
3.1.3 Growth Opportunity in Low-Penetrated Emerging Markets
3.1.4 Rapidly Evolving Consumer Behavior
3.2 Growth Drivers
3.2.1 Increasing Alumina Production
3.2.2 Growing Steel Production
3.2.3 Urban Population
3.2.4 Meliorating Global Economy
3.2.5 Growing Consumption of Beverage
3.3 Challenges
3.3.1 Stringent Regulatory Obligations
3.3.2 Negative Impact on Environment

4. Competitive Landscape
Market Share
• North America
• South America
• Europe
• China
5. Company Profiles
5.1 Ball Corporation
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
• Focus on Growth & Sustainability
• Increasing Profitability
5.2 Rexam Plc
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
• Focus on Material Efficiency
• Carbon Footprint Reduction
5.3 Crown Holdings
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
• Geographic Expansion
• Research & Development Strategy
5.4 Amcor Ltd.
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
• Increasing Presence in Emerging Markets
• Growth through Strategic Acquisitions
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948 
Email: sales@marketresearchreports.biz 
Website: http://www.marketresearchreports.biz/ 

Just Available : Global OLED Lighting Market Opportunities 2013-2023

The lighting industry is a large, global and yet fragmented market place. The fragmentation is driven both by technology differentiation and customer need diversity. The technologies vying for market share include incandescent lamp, compact fluorescent lamp (CFL), halogen lamp, light-emitting diodes (LEDs) and, most recently, organic light emitting diodes (OLED). The target markets are also very diverse, each serving different needs and demanding different price points. These markets include;

• Residential
• Architectural
• Hospitality
• Shop
• Industrial
• Office
• Outdoor

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/oled-lighting-opportunities-2013-2023-forecasts-technologies-players 

OLED and LED lighting are both solid-state technologies and offer overlapping value propositions per market segment. They will therefore compete directly in many instances. LED lighting has come a long way and offers a better performance than OLEDs, and that at a lower cost. OLED lighting will therefore only gain market success if it clearly defines its unique selling points and carves out initial market niches.

A radar chart comparing the current attributes of OLED and LED lighting

This report is divided into two parts: (a) technology and (b) market assessment. The first offers a comprehensive yet detailed overview of both LED and OLED lighting, going through fabrication processes, material compositions, technology roadmaps, and key players. The device attributes of each technology are also critically assessed, examining parameters such as colour warmth and controllability, flexibility, efficiency, surface emission, lifetime, wafer size, and luminaire design.

The second section offers a blunt market assessment. Detailed cost projection roadmaps are developed, factoring in estimated cost evolution of the integrated substrates, encapsulation layers and materials. Changes in system configuration and material composition required to enable the cost roadmaps are outlined. We also factor in production costs including capital and labour. Values are expressed in units of $/unit and $/klm.

To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172534  

The value proposition of OLEDs for all market segments is critically analysed. For each assessment, IDTechEx Research examines parameters such as light quality, form factor, technology mix diversity, price sensitivity, light controllability, lifetime and light intensity. The report also rigorously compares the performance of OLED and LED devices using the above parameters.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948 
Email: sales@marketresearchreports.biz 
Website: http://www.marketresearchreports.biz/ 

Latest Release On China Rare Earth Permanent Magnet Industry Report, 2012-2015

Amid the global economic downturn and the falling prices of upstream rare earth raw materials and NdFeB products, the demand for downstream NdFeB dropped dramatically in 2012. China’s NdFeB apparent consumption will rebound stably in the wake of the recovered demand in consumer electronics, automotive motors and other major downstream industries since 2013.

To Read The Complete Report with  TOC :  www.marketresearchreports.biz/analysis-details/china-rare-earth-permanent-magnet-industry-report-2012-2015

China Rare Earth Permanent Magnet Industry Report, 2012-2015 analyzes the global and Chinese rare earth permanent magnet markets as well as forecasts development trends from the angles of rare earth raw material supply, rare earth permanent magnet supply and demand, market prices and major production enterprises.

In H1 2012, the operating rate of China NdFeB industry was less than 50%. High-end NdFeB manufacturers maintained the operating rate as high as 70%-75%, while low-end NdFeB companies only saw 30%-40%. Since 2013, downstream industries have transferred from “de-stocking” to “re-stocking”, which stimulated the growth in orders for NdFeB and boosted the industrial operating rate obviously. In Q2 2013, the operating rate of major Chinese NdFeB producers returned to 70-80%.

By 2014 when the patent licenses of Japanese Sumitomo and U.S. Magnequench will expire in European, American and Japanese NdFeB markets, Chinese NdFeB enterprises will witness breakthroughs in export, but eight of them who hold export patent licenses (including Zhong Ke San Huan and Ningbo Yunsheng) will also face fierce competition herein.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Research Report on Global and China Monoclonal Antibody Industry, 2013-2017

Antibody drugs are usually generated from monoclonal antibody through genetic engineering, with the advantages of strong targeting, few side effects, etc. With rather promising application prospect in clinic treatment, antibody drugs are mainly applied in curing diseases like tumour, immune system and so on. In terms of the global market, antibody drugs account for over 40% of the entire biotech drug market and the market share still keeps increasing. Antibody drugs have become one of the most important parts of biotech drugs and monoclonal antibody drugs are even star products of antibody drugs. Among the top 10 best selling drugs in 2012, six of them were monoclonal antibody drugs with each annual sales value exceeding USD 5 billion.

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/research-report-on-global-and-china-monoclonal-antibody-industry-2013-2017

In recent years, the market scale of monoclonal antibody drugs increased rapidly. In 2012, the global sales value of monoclonal antibody preparation exceeded USD 50 billion. Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avastin, Herceptin, Rituximab, etc. In 2012, its sales value of monoclonal antibody products reached USD 20 billion. Mono antibody drugs will become the main force promoting the development of biological drugs in the next few years.

To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172373

In recent years, China bio pharmaceuticals industry develops rapidly, but antibody drugs lag far behind the average international level with sales value being less than 3% of biological drug share. At present, China antibody drug market is still in the initial stage. However, with Shanghai CITIC National Health Pharmaceutical Co., Ltd. and Biotech Pharmaceutical Co., Ltd. releasing humanization products, product types of domestic antibody drugs will enter the upgrading stage. Although domestic full humanization products have not been released, humanization products and full humanization products will become the domestic trend of monoclonal antibody products in the future.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://mresearchreports.blogspot.com/

Challenges and Opportunities in the Renal Denervation Market

Hypertension: Prevalence and Significance

Hypertension is one of the most preventable causes of premature morbidity and mortality globally. It is a major risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, peripheral vascular disease, cognitive decline, damage to retinal blood vessels and visual impairment, and premature death. Therefore, reducing hypertension can lower the incidence of these conditions, helping to improve the health of the population and reducing the high burdens that they place on global healthcare systems.

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/challenges-and-opportunities-in-the-renal-denervation-market

Renal denervation therapy involves a surgical procedure and is therefore a last resort in the treatment of hypertension. It is only considered when cheaper, simpler and potentially safer alternatives such as lifestyle modifications and the use of pharmaceuticals have failed. These patients are termed as having treatment-resistant hypertension.

To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172371

Current Trends and Future Opportunities

With renal denervation technology only having been in development since the late 1990s and commercially-available since 2010, the market is in its infancy. The products remain unapproved in the US and Japan, and reimbursement is not yet widely available in other regions. Despite being an emerging market, renal denervation has sparked considerable interest due to the good safety and efficacy results it has achieved so far in helping to reduce treatment-resistant hypertension. The expectation is that renal denervation could become a multi-billion dollar market in the future. However, the success of any new medical technology is dependent on regulatory approval and reimbursement; acceptance and awareness from the medical community; and evidence of safety, efficacy and cost-effectiveness. All of these elements must be in place for the market to realise its potential.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://mresearchreports.blogspot.com/

High Voltage DC Power Supply Industry in China, 2013-2017

With the development of power electronics technology and the emergence of new high-performance, high withstanding voltage and high-frequency power electronic devices, high voltage DC power supply is widely applied in industry, agriculture, health care, defense and scientific research, such as: X-ray tube, bone density testing, analytical instruments, electrophoresis, semiconductors, ion implantation, lithography, non-destructive testing, X-ray imaging, electrostatic dust removal, lampblack purification, electrostatic spraying, CT machines, laser equipment, ozone equipment, etc.

To Read The Complete Report with  TOC :  http://www.marketresearchreports.biz/analysis-details/research-and-development-forecast-of-high-voltage-dc-power-supply-in-china-2013-2017

At present, technological gap between domestic high voltage power supply products and that in foreign countries still exist; a large quantity of core devices had to rely on imports so as to guarantee the products quality.

To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172014

The survey of Huidian Research shows that since 2008, with the widening of the application areas, HVDC power supply showed a rapid growth rate; the average annual growth rate was higher than 60%. Impacted by the macro environment in 2012, the growth speed was slowed down; the sales volume was 160,000 units, up 33% YoY; the sales revenue was CNY 1.8 billion, up 38% YoY. Because the quality of the domestic core devices is relatively poor, a large number of products are imported from foreign counties; the imported products account for about 1/3 of the market share currently. 

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/